Challenges in clinical trial recruitment are particularly prevalent in PD studies of disease modification, where the population of interest is difficult to find and study design is more complex. In fact, a recent PD clinical study showed that 55.6% of sites fell below projected recruitment goals.
Clinical trials in neurological diseases present a wide range of challenges and special considerations across the board. With the right experienced study team, a patient and disease pathobiology disease centered study process can be applied to mitigate many of those challenges.
Strict Processes Rescue Complex MS Trial: Biorasi’s Project Management-first Approach Allows Rapid Feasibility and Site Startup to Meet Critical Deadlines
It is estimated that the number of PD cases is likely to grow significantly as populations grow older around the world and it is predicted that PD prevalence will at least double by 2030 in the US alone. As a result, it has become increasingly clear that these novel PD treatments and others need to be advancing to reach the clinical realm.
